Search

Pharmaceutical Proteins Wacker Starts Production

| Editor: Dr. Jörg Kempf

Related Companies

Dr. Thomas Maier, managing director of Wacker Biotech, is glad about the new units. (Picture: Wacker)
Dr. Thomas Maier, managing director of Wacker Biotech, is glad about the new units. (Picture: Wacker)

Jena/Germany (fel) – Wacker has opened a new production facility for pharmaceutical proteins (biologics) in Jena. The existing GMP-certified facility now has twice as much production area. A completely new facility for product-purification enables up to three times higher product yields per batch. The new unit meets the GMP requirements of both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA). The expansion, together with the new building for process development and quality control already completed last year, brings Wacker’s total investment in the Jena facility to some € 18 million.

(ID:20998960)